I first heard the term “censorship-industrial complex” on April 15, 2025.
That’s when I got the tip that a small office in the U.S. State Department, which focused on monitoring and countering foreign disinformation from the likes of Russia, Iran, and China, was facing imminent shutdown—the next...
As of this week in Montana, any biotech company with an experimental drug has a clear path to selling it to consumers. Companies whose drugs have been through preliminary testing—sometimes in as few as 10 healthy people—can pay $12,500 to apply to a newly established review board for approval. Once ...